Primitive neuroectodermal tumors (PNETs) such as human medulloblastomas are genetically heterogeneous and therefore poorly understood. In a rat model the SV40 large T antigen was used to induce neoplasms with characteristic features of PNETs. Tumor development requires a latency period of 8 ± 11 months implicating secondary genetic alterations. To identify such secondary alterations we performed comparative analyses of two phenotypically identical PNET-derived cell lines. Indeed, these cell lines displayed distinct high-level ampli®cation sites. Using a combination of subtractive cDNA analysis and radiation hybrid mapping we have now identi®ed genes in the amplicon regions of the two cell lines. Interestingly, one of these genes encodes the rat homolog of a cytosolic branched chain aminotransferase (BCAT C ) previously shown to be ampli®ed in a mouse teratocarcinoma cell line. We propose that this simple cloning strategy may serve as a powerful tool for the isolation of genes implicated in known chromosomal aberrations in primary tumors and tumor cell lines. Oncogene (2001Oncogene ( ) 20, 2023Oncogene ( ± 2031 
Introduction
The SV40 early region encoding the potent oncogenes large and small T-antigen has been widely used to generate animal models for human cancers and to establish permanent and transformed cell lines in vitro (Frederiksen et al., 1988; Jat and Sharp, 1989; Fung and Trojanowski, 1995; Furth, 1998; Hahn et al., 1999) . In particular, retrovirus-mediated transfer of large T antigen into rat fetal brain transplants induces speci®cally and reproducibly so-called primitive neuroectodermal tumors (PNETs) with striking similarities to human medulloblastomas (Eibl et al., 1994) . The initial event in large T antigen-mediated transformation involves interaction with and inactivation of the tumor suppressor proteins Rb and p53 thereby provoking a proliferative state and preventing apoptosis (reviewed by Ludlow and Skuse, 1995) . However, both the transformation process of primary cells in vitro or in transgenic animals in vivo is rather inecient. PNET development requires a long latency period of 8 ± 11 months (Eibl et al., 1994; Weggen et al., 1997) suggesting the involvement of secondary genetic events. Few attempts to characterize such secondary genetic alterations have been published to date (Banga et al., 1997; Held et al., 1994a,b; Sargent et al., 1997) . These secondary alterations might be dierent in every individual tumor. Thus, comparative analyses of phenotypically identical tumor cells, which were induced by the same agent (i.e. large T antigen) should provide information about the spectrum of alterations that can occur in a particular tumor type. This may allow identi®cation of co-factors involved in the development and progression of this type of tumor. The PNET cell lines TZ102 and TZ103 were chosen as a model to investigate this issue.
These cell lines are derived from individual PNET bearing rats the tumors of which had been induced by large T antigen (Weggen et al., 1997) . The cell lines display identical biological behavior in vitro and in vivo, they exhibit an immature phenotype with expression of early neural markers (Weggen et al., 1997) . They can be transplanted into adult syngenic rats where they retain the migratory properties of the primary tumors and give rise to secondary tumors . Comparative genomic hybridization (CGH) analysis revealed single and distinct high-level ampli®cation sites, cell line TZ102 on rat chromosome 2q34 and cell line TZ103 on rat chromosome 4q43qter (Kappler et al., 1999) . The chromosomal region 2q34 includes the rat N-ras oncogene and strong overexpression of N-RAS protein in cell line TZ102 has been shown by Western blot analysis (Kappler et al., 1999; de Stoppelaar et al., 1994) .
In the present study we set out to further identify genes from these ampli®cation sites assuming that some of these genes might contribute to malignant transformation. In combining suppression subtractive hybridization (SSH) cDNA cloning (Diatchenko et al., 1996) and chromosomal mapping of candidate clones we identi®ed the cytosolic branched chain aminotransferase (BCAT C ) as one of the ampli®ed and overexpressed genes on chromosome 4q43qter. This gene might be of signi®cance for tumor development or maintenance.
Results

Cloning strategy
To identify genes in the ampli®ed regions 2q34 and 4q43qter in PNET cell lines TZ102 and TZ103, respectively, we employed the suppression subtractive hybridization (SSH) technique (Diatchenko et al., 1996) . This strategy was based on two assumptions, ®rst, the target genes of the ampli®cation sites are robustly overexpressed and second, due to their similar phenotypes, the overall mRNA composition of the two cell lines should be largely identical. Thus, subtracted cDNA libraries should be highly enriched for cDNAs transcribed from the ampli®ed genomic regions. The overall strategy, as outlined in Figure 1 , was as follows. Both, a forward subtraction with TZ102 as`tester' cDNA and TZ103 as`driver' cDNA, and a reverse subtraction with TZ103 as tester' and TZ102 as`driver' cDNA were performed. Dierential expression of resulting clones was examined by dot blot hybridization. Positive clones were then further characterized by sequencing and BLAST analysis.
Since ampli®cation and overexpression of the Nras gene in cell line TZ102 had already been shown by CGH and Western blot analysis, enrichment for Figure 1 Cloning strategy to identify ampli®ed genes in rat PNET cell lines Cloning of amplified genes from SV40 large T antigen-induced PNET cell lines S Weggen et al N-ras clones in the forward subtraction library was regarded as a positive control for the eciency of the procedure. To identify cDNA clones from TZ103 that mapped to the ampli®cation site 4q43qter, the chromosomal localization of candidate clones was determined by radiation hybrid mapping. Finally, overexpression of a positive cDNA clone was con®rmed by Northern blot analysis.
Clones of the forward subtraction (TZ102`tester') Ninety-six clones from the forward subtraction were randomly selected and tested for dierential expression by dot blot analysis. Only 20 of these displayed dierential expression (data not shown). Of these, eight identical clones matched with the N-ras mRNA sequence. Two other identical clones corresponded to part of the unr mRNA. The unr mRNA encodes a protein of unknown function with DNA-binding motives (Ferrer et al., 1999) . The 3' end of the mouse unr gene is located 130 bp upstream of the transcriptional start site of the N-ras gene and this tandem arrangement is conserved in the rat and in other mammals (Jeers et al., 1990) . Furthermore, there were two identical clones each of the presumptive homolog of human S-adenosylhomocysteinase and of rat EST AA851914. Finally, six clones occurred only once, ®ve of which corresponded to known rat or mouse ESTs and one was identi®ed as part of the retroviral vector pLXSN. Data are summarized in Table 1 . These results suggest co-ampli®cation of at least the unr and Nras genes and argues for enrichment of cDNAs transcribed from the ampli®cation site 2q34, thus demonstrating the eciency of the subtraction procedure. Whether the other cDNAs were also derived from the ampli®ed region was not further investigated.
Clones from the reverse subtraction (TZ103`tester')
Of the reverse subtraction again 96 clones were randomly selected for dot blot hybridization, 18 of which exhibited dierential expression between the two cell lines (data not shown). Thus, in each case about 20% of the original clones displayed dierential expression. The remaining clones were regarded as false positives. All of the 18 clones from the reverse subtraction represented individual clones, nine of them matched with known full-length rat cDNA sequences, three were partially identical to known rat ESTs, ®ve clones showed homology to mouse ESTs and one cDNA clone was homologous to a human EST (see Table 2 ). To see, whether any of the isolated cDNA clones from TZ103 cells were derived from the ampli®cation site of chromosome 4q43qter, three clones were further analysed by radiation hybrid mapping. One interesting candidate (clone 12) exhibited sequence identity to rat EST AA900881 and homology to a mouse mRNA that was shown to be overexpressed and ampli®ed in the teratocarcinoma cell line ECA39 (Niwa et al., 1990) . The others were selected at random and included cDNA clone 16 with sequence identity to cytosolic protein tyrosine phosphatase RKPTP (Moriyama et al., 1994) and clone 2 with homology to mouse EST AA672232.
Chromosomal localization of clones from the reverse subtraction by radiation hybrid mapping
To determine whether one of the three cDNA clones mapped to the ampli®ed region 4q43qter, a genomic PCR was established for each clone and used to screen 96 hybrid lines of a rat radiation hybrid panel for the presence of the target-sequence. Positive hybrids are listed in Table 3 . In addition, the hybrid lines were Cloning of amplified genes from SV40 large T antigen-induced PNET cell lines S Weggen et al screened for the integrity of four known rat microsatellite sequences of the telomeric region of chromosome 4q (markers D4RAT68, D4RAT70, D4RAT72, and D4RAT141) (Steen et al., 1999) . Two-point analysis revealed linkage between markers D4RAT68, D4RAT70, D4RAT72 and the cDNA clone EST AA900881 (lodscore 8), while RKPTP and EST AA672232 showed no linkage to this group. Multipoint analysis as described by Boehnke et al. (1991) was performed to assess the relative order of the markers with respect to each other. This placed the rat EST AA900881 between the markers D4RAT68 and D4RAT70 in the order D4RAT68, AA900881, D4RAT70, D4RAT72. The results of the statistical analysis were con®rmed by the Rat Radiation Hybrid
Mapping Server which placed the rat EST AA900881 between the markers D4RAT70 and D4RAT140 at the distal end of chromosome 4q (lodscore 20). That the EST AA900881 cDNA was indeed derived from an ampli®ed region was investigated by quantitative PCR using the b-actin gene as internal standard. Genomic DNAs from TZ102 and TZ103 cells were used as templates. This experiment revealed that the gene corresponding to AA900881 was indeed ampli®ed about three times in TZ103 relative to TZ102 (data not shown).
Cloning of a full-length cDNA for rat EST AA900881
Using the EST AA900881 cDNA fragment obtained by SSH as probe for screening a cDNA library from TZ103 cells, we identi®ed 62 positive clones out of 150 000 clones con®rming a high level of expression. Ten of the original 62 plaques were tested by PCR and one of the positive clones was plaque-puri®ed and sequenced. Sequencing of the full-length cDNA clone determined a 2493 nucleotide sequence with an open reading frame for 399 amino acids, preceeded by 126 nucleotides of 5'UTR and followed by 1166 nucleotides of 3' UTR. Genbank database search revealed that the isolated cDNA clone is virtually identical to the rat cytosolic branched chain aminotransferase (BCAT C ; Hutson et al., 1996) . However, multiple sequence alignments of the deduced amino acid sequence of BCAT C from TZ103 cells with the published sequences of rat and murine BCAT C revealed that the N-terminus of BCAT C cloned from TZ103 cells was more closely related to the murine rather than the published rat sequence (see Figure 2) . While the N-termini of murine and TZ103 BCAT C both start with MK followed by DCSN... the published rat BCAT C begins with the sequence MYLSRATATLARQ followed by the common sequence DCSN... (Hutson et al., 1996) . To rule 9, 23, 27, 28, 29, 39, 47, 49, 50, 52, 57, 59, 75, 80, 99, 100, FR D4RAT70 9, 17, 18, 23, 27, 29, 36, 39, 44, 47, 49, 52, 55, 57 75, 76, 80, 82, 84, 87, 88, 96, 99, FR D4RAT72 14, 17, 18, 23, 27, 29, 33, 36, 37, 39, 44, 47, 49, 52 55, 59, 73, 75, 77, 80, 82, 84, 87, 88, 96, 99, FR D4RAT141 6, 8, 19, 22, 23, 27, 36, 39, 44, 49, 50, 52, 55, 57, 59, 64, 65, 68, 72, 75, 76, 80, 88, 89, 95, 97, 99, 100, FR RKPTP 7, 10, 12, 16, 18, 25, 27, 33, 44, 45, 46, 49, 50, 55, 56, 59, 61, 62, 63, 67, 68, 69, 70, 71, 80, 83, 85, 86, 87, 88, 92, 94, 100, FR AA672232 5, 7, 9, 12, 22, 23, 24, 25, 29, 44, 45, 46, 48, 50, 52, 58, 59, 64, 65, 67, 70, 71, 72, 80, 84, 94, 96, 97, 99, 100, FR AA900881 9, 23, 27, 29, 33, 36, 39, 47, 49, 50, 52, 55, 57, 75, 80, 88, 96, 99, 100, FR To conform to a 96-well format only hybrids 2 ± 19, 21 ± 34, 36 ± 37, 39 ± 59, 61 ± 89 and 91 ± 100 of the available 106 hybrid lines were used. DNA from cell line RatFR was included as a positive control. Hybrid lines that gave rise to a PCR product are indicated
Cloning of amplified genes from SV40 large T antigen-induced PNET cell lines S Weggen et al out that these dierences resulted from cloning artifacts, a 337 bp DNA fragment spanning the Nterminal region of BCAT C was ampli®ed by RT ± PCR with RNA from TZ103 cells and sequenced. This sequence was identical to that of the original full-length cDNA clone (data not shown).
Differential expression of BCAT C in TZ102, TZ103, and other PNET cell lines
To con®rm the overexpression of BCAT C in the cell line TZ103, Northern blot analysis was performed with total RNA isolated from TZ102 and TZ103 cells using full-length cDNA as probe. Figure 3a shows a strong signal of a single mRNA transcript of approximately 2.5 kb in TZ103 cells, whereas only weak expression was detected in TZ102 cells. Figure 3b demonstrates identical loading and integrity of the RNA. Quanti®ca-tion by densitometry of BCAT C expression relative to GAPDH expression (Figure 3c ) revealed an 8.5-fold higher expression of BCAT C in TZ103 versus TZ102 cells. However, GAPDH expression seemed to dier reversely in the two cell lines (Figure 3c ). Thus, assuming identical loading (deduced from Figure 3b ) Figure 2 Multiple sequence alignment of eukaryotic branched chain aminotransferases (BCAT). The deduced amino acid sequence of rat BCAT C isolated from PNET cell line TZ103 (denoted TZ103 BCATc) (accession number AJ278701) was aligned with mouse ECA39 (murine BCAT C ; Niwa et al., 1990 ) (accession number X17502), the previously described rat BCAT C (Hutson et al., 1996) , and the recently submitted sequence of rat BCATc from Kholodilov et al. (2000) (accession number AF165887). The dierences in the rat sequences are highlighted the dierence in BCAT expression may be only ®vefold. Since BCAT C was shown to be overexpressed in a mouse teratocarcinoma cell line we asked whether high expression of this gene might be of signi®cance for tumor progression and whether other PNET cell lines would exhibit dierential expression of BCAT C , too.
To this end, we analysed two cell lines that dier greatly in their tumorigenicity, TZ870, a large T antigen-induced PNET cell line which does not grow in soft agar and does not give rise to tumors in vivo, and a highly malignant clonal derivative thereof, LT-0 (Salewski et al., 1999) . Strikingly, the malignant LT-0 cell line exhibited high expression of BCAT C , similar to TZ103, while TZ870 showed only a low level of expression the dierence being about 15-fold. Whether this overexpression of BCAT C in the LT-0 cell clone was due to ampli®cation was not investigated.
Discussion
The initial and decisive event in PNET induction by large T antigen is most likely the inactivation of tumorsuppressor proteins Rb and p53, as shown by numerous studies on other models. Yet, this inactivation is necessary but not sucient. Tumor development requires a long latency period of 8 ± 11 months suggesting that full transformation of neuroectodermal precursor cells requires additional genetic alterations (Weggen et al., 1997; Eibl et al., 1994) . These secondary changes could be similar or completely dierent in individual tumors. In the ®rst case, one could derive a generalized model with a de®ned sequence of events, as described for colon carcinogenesis (Kinzler and Vogelstein, 1996) . This would suggest restriction to or selection for particular changes as suggested by McCormick (1999) . In the latter case, it is hard to derive a concisive model. PNETs may belong to the second group since they display a great spectrum of genetic alterations. Our strategy to identify secondary genetic events that might contribute to tumor development, was to compare tumor cell lines that were derived from individual tumors yet transformed by the same agent, large T antigen, and that were phenotypically similar. The PNET cell lines TZ102 and TZ103 seemed to be a suitable model. They exhibit similar properties with respect to growth in cell culture, in soft agar, tumor induction and expression of dierentiation markers (Weggen et al., 1997) . A previous study revealed distinct high-level ampli®cation sites, 2q34 and 4q43qter, respectively, in these cell lines which argues for divergent pathways of tumor development in this PNET model (Kappler et al., 1999) . The 2q34 locus contains the N-ras gene (de Stoppelaar et al., 1994) which was indeed ampli®ed and highly overexpressed in TZ102 cells (Kappler et al., 1999) . In this study, we sought to identify further genes which were ampli®ed in the two cell lines using subtractive cDNA analysis.
That this approach worked in principle was exempli®ed by the enrichment for N-ras clones (eight out of 20) and unr clones (two out of 20). Since the unr gene is intimately linked to the N-ras locus, this result suggests co-ampli®cation of these genes (Jeers et al., 1990) . Two other clones were found twice suggesting that they too may be derived from the ampli®cation locus. However, it must be emphasized that the level of transcription does not necessarily re¯ect the level of ampli®cation and overexpression of a particular mRNA can of course result from other mechanisms.
Despite these theoretical limitations we were able to identify one clone transcribed from the amplicon at 4q43qter in cell line TZ103, as revealed by radiation hybrid mapping and quantitative genomic PCR. This clone, identi®ed as rat cytosolic branched-chain aminotransferase (BCAT C ) (Hutson et al., 1996) was highly overexpressed (5 ± 8-fold) in TZ103 cells compared with TZ102 cells.
Interestingly, alignment and detailed inspection of the amino acid sequence of the rat BCAT C from TZ103 cells with the previously identi®ed murine BCAT C (Niwa et al., 1990) and rat BCAT C (Hutson et al., 1996) revealed striking dierences at the Ntermini where our sequence was completely identical to the murine BCAT C (Niwa et al., 1990) , whereas the sequence of rat BCAT C published by Hutson et al. (1996) contained an N-terminal extension. Whether this 
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Cloning of amplified genes from SV40 large T antigen-induced PNET cell lines S Weggen et al extension re¯ects a polymorphism or is due to an extra exon and whether it has any functional implications is so far not known.
Significance of the amplified and overexpressed genes for tumor development
Ampli®cation and overexpression of N-ras in TZ102 is certainly of signi®cance. In a recent model by Hahn et al. (1999) it was shown that the concerted action of large T antigen (leading to inactivation of Rb and p53) and activated ras is sucient to transform primary mouse cells while expression of telomerase is additionally required for transformation of human cells.
Whether the other genes that were perhaps coampli®ed and/or overexpressed in TZ102 would contribute to tumor progression needs to be investigated. The BCAT genes have so far not been implicated in malignant transformation. These enzymes regulate the ®rst step in the catabolic pathway of essential branched chain amino acids. A mitochondrial enzyme (BCAT m ) is ubiquitously expressed, whereas a cytosolic isoenzyme (BCAT C ) is predominantly found in brain and to a lesser extent in placenta and ovary (Hall et al., 1993) . In a recent study BCAT C was shown to be upregulated in surviving substantia nigra neurons after a developmental striatal target lesion suggesting that increased expression of BCAT C may be required to meet the higher metabolic demands of surviving neurons (Kholodilov et al., 2000) . Therefore, ampli®cation of BCAT C in TZ103 cells could contribute to an increased rate of protein synthesis in rapidly dividing tumor cells. This view is supported by the following ®ndings. (1) The mouse homolog of this gene has previously been shown to be ampli®ed and overexpressed in a teratocarcinoma cell line (Niwa et al., 1990) . (2) In an independent approach, this gene was isolated from c-myc induced mouse tumors and it has been demonstrated to be a direct target for c-myc activation (Benvenisty et al., 1992; Ben-Yosef et al., 1996) . (3) Spontaneous conversion of TZ870 cells to the highly malignant derivatives, LT-0 cells (Salewski et al., 1999), was obviously accompanied by overexpression of BCAT (this study). Thus, the ampli®cation of BCAT C in three cell lines derived from embryonal neoplasms of dierent species supports the idea that this enzyme may play a role in tumor development. Whether BCAT C has direct transforming activity or just contributes to maintain the transformed state by satisfying the higher nutritional demands of cancer cells can be experimentally tested now.
Other questions concern the signi®cance of the remaining clones that were overexpressed, whether they are derived from the ampli®ed region and, more importantly, whether their dysregulation contributes to malignant progression. They include several clones of unknown function that need to be characterized.
In summary, our comparative analyses on individual large T antigen-induced PNET cell lines revealed distinct ampli®ed regions that re¯ect the diversity of secondary genetic alterations. The SSH technique allows identi®cation of transcripts derived from such amplicons and further investigations on their possible involvement in oncogenesis.
Materials and methods
Cell culture
The PNET cell lines TZ102, TZ103, and TZ870 were derived from individual tumor-bearing rats, the tumors of which had been induced by retroviral gene transfer of the large T antigen gene into fetal brain transplants (Eibl et al., 1994; Weggen et al., 1997) . LT-0 cell line is a highly malignant derivative of TZ870 that is lacking the large T gene but has suered additional genetic alterations (Salewski et al., 1999) . Cells were grown in DMEM medium (Life Technologies, Inc, Eggenstein, Germany) supplemented with 10% fetal bovine serum (Life Technologies, Inc.) and 100 U/ml penicillin and 100 U/ml streptomycin. TZ102 and TZ103 cell lines contain a single high-level ampli®cation site on rat chromosome 2q34 and on chromosome 4q43qter, respectively (Kappler et al., 1999) .
Isolation of total RNA and poly(A)
+ mRNA
Total cellular RNA was extracted from 80% con¯uent cells with TRIZOL TM reagent (Life Technologies, Inc.) according to the manufacturer's instructions. Poly(A) + mRNA was isolated with the Oligotex mRNA Kit (Qiagen, DuÈ sseldorf, Germany). A total of 2 mg poly(A) + mRNA from each cell line was precipitated in 10% glycogen, 0.33 M potassium acetate, and 70% ethanol for 1 h at 7208C. The pellet was washed with 70% ethanol and dissolved in 4 ml DEPCtreated water for ®rst-strand cDNA synthesis.
Generation of subtracted cDNA libraries by suppression subtractive hybridization (SHH)
Suppression subtractive hybridization (Diatchenko et al., 1996) was performed using the PCR-Select TM cDNA Subtraction Kit (Clontech Laboratories, Heidelberg, Germany) according to the manufacturer's recommendations. A forward subtraction with TZ102 as`tester' cDNA and TZ103 as`driver' cDNA, and a reverse subtraction with TZ103 as tester' cDNA and TZ102 as`driver' cDNA was performed. All PCR and hybridization steps were performed on a Perkin-Elmer GeneAmp 9600 thermal cycler using the Advantage 1 2 Polymerase Mix (Clontech).
Cloning of subtracted cDNA libraries and screening for differential expression PCR ampli®ed subtracted cDNA libraries were inserted into plasmid vector pCR2.1 using the TOPO TA Cloning 1 Kit (Invitrogen, San Diego, CA, USA) and electroporated into ElectroMAX TM DH10B TM cells (Life Technologies Inc.). Transformed bacteria were plated onto 22622 cm ampicillin-containing agar plates. Ninety-six colonies from each, the forward and the reverse subtracted libraries were randomly picked and screened for dierential expression between cell lines TZ102 and TZ103 with a dot blot assay using the PCRSelect Dierential Screening Kit (Clontech).
Sequencing and computer analysis of differentially expressed cDNA clones
Cycle sequencing of dierentially expressed cDNA clones was carried out using a Fluorescent Dideoxy Terminator Kit (ABI) and products were analysed on an Applied Biosystems model 373A DNA sequencer. Gene database searches were performed through the National Center for Biotechnology Information (National Institutes of Health, Bethesda, MD, USA) and through the EMBL Gene Database (Heidelberg, Germany) using the BLAST analysis program.
Radiation hybrid mapping
Radiation hybrid mapping of dierentially expressed cDNA clones from the reverse subtraction (TZ103 as`tester' cDNA) was performed with the Rat RH Panel (Research Genetics, Huntsville, AL, USA). This radiation hybrid panel was generated by fusion of the irradiated rat ®broblast cell line RatFR with the hamster cell line A23. To conform to a 96-well format only 94 of the available 106 hybrid lines were used. Our analysis included the hybrids 2 ± 19, 21 ± 34, 36 ± 37, 39 ± 59, 61 ± 89 and 91 ± 100. DNA from cell line RatFR was included as a positive control, DNA from hamster cell line A23 as a negative control in all PCR reactions. To screen the radiation hybrid panel a genomic PCR with DNA from cell line RatFR as template was established for three candidate clones (clones RKPTP, AA900881, and AA672232). Primers (5'-TAAGTCAGCGGACCTAATGG-3'), (RKPTP-forward) and (5'-AAACTTTTGGGCCCTTCTTGG-3'), (RKPTP-reverse) were used to amplify a 120 bp fragment from the cDNA clone RKPTP. Primers (5'-TACATGCTG CCCG-AATCAGG-3') and (5'-TGCTATGAGACTAGGGGTCC-3') were used to amplify a 167 bp fragment from the cDNA clone with sequence identity to the rat EST AA900881. Primers (5'-TGGCTTCATGATCATGCAGG-3') and (5'-TTCCTTTCATGGGTGACACC-3') were used to amplify a 120 bp fragment from the cDNA clone with sequence identity to the rat EST AA900881. Likewise primers of four known rat microsatellite markers (D4RAT72, D4RAT70, D4RAT68, D4RAT141) located to the telomeric region of chromosome 4q were used to screen the radiation hybrid panel. D4RAT72 is located at the distal end of chromosome 4q followed by D4RAT70, D4RAT68 and D4RAT141 in proximal orientation (Steen et al., 1999) . The following primers were used: for D4RAT72: (5'-TCTTCAGTGTTGGTAGGAAAATCA-3') and (5'-GGATGCACTGTTCTCGGTTT-3'); for D4RAT70, (5'-ATTTTCTCCTAAGTGGGCGC-3') and (5'-GCCCTCC-CTCAGTCTTCTT-3'); for D4RAT68, (5'-TTCCCAAGT-GCTGGAGTTGT-3') and (5'-CAGGACTTGGTGCATGC-TAA-3'); for D4RAT141, (5'-TCTTCTGCTCTCACAG-TCGG-3') and (5'-TAATCGCAGATCCCCCAATA-3'). To assess linkage between the microsatellite markers and the candidate clones and to order linkage groups two-point and multi-point statistical analysis was performed as described (Cox et al., 1990; Boehnke et al., 1991) 
Isolation of a full-length cDNA clone
For the generation of a cDNA library from TZ103 cells, we employed puri®ed poly(A) + mRNA from TZ103 cells as described above. Reverse transcription was performed with the ZAPExpress TM cDNA synthesis kit according to the manufacturer's speci®cations (Stratagene, La Jolla, CA, USA). In this way, the cDNA libraries were inserted into the HybriZAP TM vector (Short et al., 1988) fused to the transactivation domain of GAL4 which, after excision, revealed the pAD-GAL4-cDNA phagemide. For the isolation of the full-length cDNA clone corresponding to rat EST AA900881, this cDNA library was screened with a 32 P-labeled 800 bp insert derived from SSH and subcloned into pCR2.1. Labeling with a-32 P-dCTP was performed with Klenow polymerase using the Megaprime Labeling Kit (Amersham Pharmacia Biotech, Freiburg, Germany). Of 150 000 individual phage clones screened, 62 positive plaques were identi®ed by autoradiography. One of these clones was isolated as a phagemide clone and completely sequenced.
RT ± PCR
RT ± PCR with RNA isolated from TZ103 cells (see above) was employed to amplify a 337 bp DNA fragment spanning the N-terminal region of BCAT C with the sense primer (5'-CTCTCCATCTTCCGCGCTTGC-3') and the antisense primer (5'-CCACTCCACCATCAGCATGTGG-3'). Reaction products of the predicted size were subsequently cloned into plasmid vector pCR2.1 using the TOPO TA Cloning 1 Kit (Invitrogen) and sequenced.
Northern blot analysis and quantification
Total RNA (26 mg) from TZ102, TZ103, TZ870, and LT-0 cells was separated on 1% formaldehyde denaturated agarose and capillary transferred onto Hybond-N membrane (Amersham). The membrane was prehybridized at 428C in 50% deionized formamide, 56SSC, 56Denhardt's solution, 0.5% sodium dodecyl sulfate (SDS), 100 mg/ml of denaturated salmon sperm DNA and 100 mg/ml tRNA. The blot was hybridized with the a-32 P-dCTP-labeled full-length cDNA generated by excision from the yeast pAD-GAL4 vector with MluI and XbaI overnight at 428C and processed according to standard procedures (Sambrook et al., 1989) . After autoradiography, the membrane was dehybridized by immersion in boiling 0.1% SDS and a further round of hybridization was performed with a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe. Ethidium bromide staining was used to con®rm equivalent loading of the samples. All signals were quanti®ed with the Image Master VDS Software (Pharmacia Biotech Inc., San Francisco, CA, USA) and corrected for variations in sample loading by comparison to their GAPDH expression pro®le.
